Wenkui Li

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Mass Spectrometry

Molecularly Imprinted

High Resolution Mass Spectrometry

Top Venues

Biomedical chromatography : BMC

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yunlin Fu, Wenkui Li, Franck Picard
Assessment of matrix effect in quantitative LC-MS bioanalysis. Bioanalysis 16 (12) (2024)
Yunlin Fu, Wenkui Li, Franck Picard
Assessment of matrix effect in quantitative LC-MS bioanalysis. Bioanalysis (2024)
Yunlin Fu, Wenkui Li, Franck Picard
Assessment of matrix effect in quantitative LC-MS bioanalysis. Bioanalysis 16 (12) (2024)
Yunlin Fu, Wenkui Li, Franck Picard
Assessment of matrix effect in quantitative LC-MS bioanalysis. Bioanalysis 16 (12) (2024)
Wenkui Li, Faye Vazvaei-Smith, Gordon Dear, Jason Boer, Filip Cuyckens, Daniela Fraier, Yuexia Liang, Ding Lu, Heidi Mangus, Patricia Moliner, Mette Lund Pedersen, Andrea A Romeo, Douglas K Spracklin, David S Wagner, Serge Winter, Xiaohui Sophia Xu
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group. Clinical pharmacology and therapeutics (2023)
Yunlin Fu, Wenkui Li, Franck Picard
Non-regulated LC-MS/MS bioanalysis in support of early drug development - a Novartis perspective. Bioanalysis (2023)
Wenkui Li, Franck Picard
Toxicokinetics in Preclinical Drug Development of Small Molecule New Chemical Entities. Biomedical chromatography : BMC (2022)
Yunlin Fu, Shashank Gorityala, Wenkui Li, David Humphries, Aaron Ledvina, Stephanie Cape, Franck Picard
Sensitive LC-MS/MS quantification of unconjugated maytansinoid DM4 and its metabolite S-methyl-DM4 in human plasma. Bioanalysis 14 (6) (2022)
Wenkui Li, Jim Glick, Panos Hatsis, Yunlin Fu, Harvey Chin, Paul Moench, Jimmy Flarakos
An integrated outsourcing practice of nonclinical LC-MS bioanalysis and toxicokinetics at Novartis small molecule drug development. Bioanalysis 13 (12) (2021)
Yunlin Fu, Wenkui Li, Jimmy Flarakos
Critical considerations of matrix selection in LC-MS bioanalysis for toxicokinetic and pharmacokinetic assessment in drug development. Bioanalysis 13 (8) (2021)
Wenkui Li, Ravi Dugyala, Patrick J Devine, Matthew Jardel, John Doherty, Katie Kubek, Daniel Lapadula, Jimmy Flarakos
Application of tail vein serial microsampling for plasma or dried plasma spots in toxicokinetic assessment in rats using acetaminophen as the model compound. Biomedical chromatography : BMC 34 (10) (2020)
Deborah Barkley, Panos Hatsis, Jim Glick, Wenkui Li, Jimmy Flarakos
Dixon's Q-test and Student's t-test to assess analog internal standard response in nonregulated LC-MS/MS bioanalysis. Bioanalysis 12 (21) (2020)
Wenkui Li, John Doherty, Yunlin Fu, Jimmy Flarakos
Quantitative analysis of clofazimine (Lamprene®), an antileprosy agent, in human dried blood spots using liquid chromatography-tandem mass spectrometry. Biomedical chromatography : BMC 32 (2) (2017)